Clin Transl Med . Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

[tetano]

Clin Transl Med


. 2022 Jan;12(1):e704.
doi: 10.1002/ctm2.704.
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes


Laia Reverté ^{1 2 3} , Elena Yeregui ^{1 2} , Montserrat Olona ^{1 2 3 4} , Alicia Gutiérrez-Valencia ^{5 6} , Maria José Buzón ⁷ , Anna Martí ^{1 2} , Frederic Gómez-Bertomeu ^{1 4} , Teresa Auguet ^{1 2 4} , Luis F López-Cortés ^{5 6} , Joaquin Burgos ⁷ , Clara Benavent-Bofill ¹ , Carme Boqué ^{1 4} , Graciano García-Pardo ^{1 2 4} , Ezequiel Ruiz-Mateos ^{5 6} , Maria Teresa Mestre ¹ , Francesc Vidal ^{1 2 3 4} , Consuelo Viladés ^{1 2 3 4} , Joaquim Peraire ^{1 2 3 4} , Anna Rull ^{1 2 3 4} , COVIDOMICS Study Group



Affiliations

• PMID: 35075803
• DOI: 10.1002/ctm2.704

No abstract available